These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 2049047)

  • 21. T cell and antibody reactivity with the Borrelia burgdorferi 60-kDa heat shock protein in Lyme arthritis.
    Shanafelt MC; Hindersson P; Soderberg C; Mensi N; Turck CW; Webb D; Yssel H; Peltz G
    J Immunol; 1991 Jun; 146(11):3985-92. PubMed ID: 1709664
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Borrelia burgdorferi infection and immunity in mice deficient in the fifth component of complement.
    Bockenstedt LK; Barthold S; Deponte K; Marcantonio N; Kantor FS
    Infect Immun; 1993 May; 61(5):2104-7. PubMed ID: 8478100
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lyme carditis in immunodeficient mice during experimental infection of Borrelia burgdorferi.
    Zimmer G; Schaible UE; Kramer MD; Mall G; Museteanu C; Simon MM
    Virchows Arch A Pathol Anat Histopathol; 1990; 417(2):129-35. PubMed ID: 2114691
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Characterization of Borrelia burgdorferi associated antigens by monoclonal antibodies.
    Kramer MD; Schaible UE; Wallich R; Moter SE; Petzoldt D; Simon MM
    Immunobiology; 1990 Nov; 181(4-5):357-66. PubMed ID: 2099905
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The severe combined immunodeficiency (scid) mouse. A laboratory model for the analysis of Lyme arthritis and carditis.
    Schaible UE; Kramer MD; Museteanu C; Zimmer G; Mossmann H; Simon MM
    J Exp Med; 1989 Oct; 170(4):1427-32. PubMed ID: 2794862
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The outer surface protein A (OspA) of Borrelia burgdorferi: a vaccine candidate and bioactive mediator.
    Kramer MD; Wallich R; Simon MM
    Infection; 1996; 24(2):190-4. PubMed ID: 8740121
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Roles of OspA, OspB, and flagellin in protective immunity to Lyme borreliosis in laboratory mice.
    Fikrig E; Barthold SW; Marcantonio N; Deponte K; Kantor FS; Flavell RA
    Infect Immun; 1992 Feb; 60(2):657-61. PubMed ID: 1730500
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Borrelia burgdorferi infection. II. Aspects of basic research, new approaches to diagnosis and therapy].
    Kramer MD; Simon MM; Schaible UE; Moter SE; Wallich R
    Hautarzt; 1991 Feb; 42(2):63-71. PubMed ID: 2037491
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Protective and arthritis-resolving activity in sera of mice infected with Borrelia burgdorferi.
    Barthold SW; Feng S; Bockenstedt LK; Fikrig E; Feen K
    Clin Infect Dis; 1997 Jul; 25 Suppl 1():S9-17. PubMed ID: 9233658
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Lyme arthritis resolution with antiserum to a 37-kilodalton Borrelia burgdorferi protein.
    Feng S; Hodzic E; Barthold SW
    Infect Immun; 2000 Jul; 68(7):4169-73. PubMed ID: 10858233
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Immunoregulatory effects of Borrelia burgdorferi on T-B cell interactions.
    Goronzy JJ; Hanson TL; Weyand CM
    J Rheumatol; 1992 Apr; 19(4):573-8. PubMed ID: 1375647
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Activity of sera from patients with Lyme disease against Borrelia burgdorferi.
    Pavia CS; Wormser GP; Norman GL
    Clin Infect Dis; 1997 Jul; 25 Suppl 1():S25-30. PubMed ID: 9233660
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cellular immune response to Borrelia burgdorferi in patients with Lyme borreliosis.
    Krause A; Rensing A; Kalden JR; Burmester GR
    Behring Inst Mitt; 1991 Feb; (88):52-8. PubMed ID: 2049046
    [No Abstract]   [Full Text] [Related]  

  • 34. Localization of Borrelia burgdorferi in the nervous system and other organs in a nonhuman primate model of lyme disease.
    Cadavid D; O'Neill T; Schaefer H; Pachner AR
    Lab Invest; 2000 Jul; 80(7):1043-54. PubMed ID: 10908149
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Etiology and pathogenesis of Lyme borreliosis].
    Pokorni D; Lako B
    Glas Srp Akad Nauka Med; 1993; (43):123-32. PubMed ID: 8262397
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Killing of Borrelia burgdorferi by macrophages is dependent on oxygen radicals and nitric oxide and can be enhanced by antibodies to outer surface proteins of the spirochete.
    Modolell M; Schaible UE; Rittig M; Simon MM
    Immunol Lett; 1994 May; 40(2):139-46. PubMed ID: 8088871
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antibody-mediated disease remission in the mouse model of lyme borreliosis.
    Barthold SW; Hodzic E; Tunev S; Feng S
    Infect Immun; 2006 Aug; 74(8):4817-25. PubMed ID: 16861670
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Fas ligand deficiency impairs host inflammatory response against infection with the spirochete Borrelia burgdorferi.
    Shi C; Wolfe J; Russell JQ; Fortner K; Hardin N; Anguita J; Budd RC
    Infect Immun; 2006 Feb; 74(2):1156-60. PubMed ID: 16428764
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Myositis in mice inoculated with Borrelia burgdorferi.
    Museteanu C; Schaible UE; Stehle T; Kramer MD; Simon MM
    Am J Pathol; 1991 Dec; 139(6):1267-71. PubMed ID: 1750502
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immunologic aspects of Lyme borreliosis.
    Dattwyler RJ; Volkman DJ; Luft BJ
    Rev Infect Dis; 1989; 11 Suppl 6():S1494-8. PubMed ID: 2682961
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.